[Interleukin-2 immunotherapy and cutaneous manifestations]
- PMID: 8304709
[Interleukin-2 immunotherapy and cutaneous manifestations]
Abstract
The cutaneous manifestations which follow the administration of recombinant interleukin-2 (rIL-2) are well known, but their nature and severity have not yet been fully studied. The authors report the dermatological changes observed in 12 patients treated with rIL-2 for renal cancer. The predominant lesion was generalized erythema followed by desquamation.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical